A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

The sale resulted in a net loss of $3.0 million during the nine ... Alvotech's commercial partners include Teva ...

Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...

The market report reviews the effect of demand, supply, market share, gross margin, sale, cost, and growth rate on the global Anxiety Disorder Treatment market. It also highlights various facts and ...

The most essential rule of camping is Leave No Trace. That means anything you bring in with you, you have to bring out. This air-tight, collapsible wine container not only keeps your wine preserved ...

Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Teva Pharmaceutical Industries (NYSE:TEVA), a global leader in generic and specialty medicines, has been navigating a complex landscape of legal challenges, market competition, and strategic ...

Teva Pharmaceutical Industries (NYSE:TEVA), a global leader in generic and specialty medicines, has been navigating a complex landscape of legal challenges, market competition, and strategic growth ...